Copyright
©The Author(s) 2019.
World J Gastroenterol. Nov 28, 2019; 25(44): 6495-6507
Published online Nov 28, 2019. doi: 10.3748/wjg.v25.i44.6495
Published online Nov 28, 2019. doi: 10.3748/wjg.v25.i44.6495
Figure 5 Endogenous metadherin expression in colorectal cancer tissues.
A: metadherin (MTDH) expression levels were investigated in 15 colorectal cancer (CRC) tissue samples and matching healthy colorectal tissue samples. Results are shown for 8 colon cancer tissues in pairs. P1 to P8 indicate patients with colon cancer. Data are presented as fold change in the expression in tumor tissues relative to expression in matching healthy colon tissues. P values were calculated using Student’s t-test (aP < 0.05); B: Relative endogenous NFKB1 (n = 5) and RELA (n = 4) expression levels in colon cancer tissue samples and matching healthy colon tissue samples. Data are presented as fold change in the expression in tumor tissues relative to expression in matching healthy colon tissues; C: Immunostaining of MTDH in human CRC and adjacent healthy colorectal samples (200 × magnification). Experiments were independently performed three times in duplicates. MTDH: Metadherin.
- Citation: Han SH, Mo JS, Park WC, Chae SC. Reduced microRNA 375 in colorectal cancer upregulates metadherin-mediated signaling. World J Gastroenterol 2019; 25(44): 6495-6507
- URL: https://www.wjgnet.com/1007-9327/full/v25/i44/6495.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i44.6495